 SAN FRANCISCO and SUZHOU, China, June 16, 2021 GLOBE NEWSWIRE -- Adagene Inc. Adagene Nasdaq: ADAG, a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based immunotherapies, today announced that it will be added to the FTSE Global Equity Index Series GEIS, including the FTSE Global Total Cap Index and FTSE Emerging Total Cap Index, effective June 21, 2021. 